27.01.2016 13:36:32

Meridian Bioscience Inc. Earnings Climb 13% In Q1

(RTTNews) - Meridian Bioscience Inc. (VIVO) announced a profit for its first quarter that climbed from last year.

The company said its bottom line advanced to $8.89 million, or $0.21 per share. This was higher than $7.90 million, or $0.19 per share, in last year's first quarter.

Analysts had expected the company to earn $0.21 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 1.8% to $47.16 million. This was down from $48.01 million last year.

Meridian Bioscience Inc. earnings at a glance:

-Earnings (Q1): $8.89 Mln. vs. $7.90 Mln. last year. -Earnings Growth (Y-o-Y): 12.5% -EPS (Q1): $0.21 vs. $0.19 last year. -EPS Growth (Y-o-Y): 10.5% -Analysts Estimate: $0.21 -Revenue (Q1): $47.16 Mln vs. $48.01 Mln last year. -Revenue Change (Y-o-Y): -1.8%

Nachrichten zu Meridian Bioscience Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Meridian Bioscience Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!